David A. Gonyer serves as Executive at Evoke Pharma Inc, where they oversee executive responsibilities. Since joining the company, David A. Gonyer has executed 15 insider transactions totaling $209.8K, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 14, 2020 involved selling 23,954 shares valued at $70.4K.
David A. Gonyer currently holds 339,782 shares of Evoke Pharma Inc (EVOK), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David A. Gonyer has been a net seller of EVOK stock. They have purchased $0 and sold $209.8K worth of shares.
David A. Gonyer's most recent insider trade was on Dec 14, 2020, when they sold 23,954 shares at $2.94 per share.
Get notified when new Form 4 filings are submitted
| $2.90 |
| Discretionary |
| Dec 9, 2020 | EVOK | $28.8K | Option Exercise | 72,000 | $0.40 | Discretionary |
| Sep 1, 2020 | EVOK | $21.2K | Other | 20,238 | $1.05 | Discretionary |
| Aug 31, 2018 | EVOK | $11.2K | Other | 6,901 | $1.63 | Discretionary |
| Aug 31, 2017 | EVOK | $17.7K | Other | 8,240 | $2.15 | Discretionary |
| Feb 28, 2017 | EVOK | $19.2K | Other | 12,000 | $1.60 | Discretionary |
| Mar 1, 2016 | EVOK | $13.5K | Other | 4,669 | $2.90 | Discretionary |
| Aug 31, 2015 | EVOK | $13.3K | Other | 4,023 | $3.31 | Discretionary |
| Aug 6, 2015 | SGNL | $0 | Option Exercise | 4,125 | $N/A | Discretionary |
| Aug 6, 2015 | SGNL | $0 | Award | 5,000 | $N/A | Discretionary |
| Jul 17, 2015 | SGNL | $0 | Option Exercise | 1,375 | $N/A | Discretionary |
| Feb 27, 2015 | EVOK | $12.9K | Other | 2,711 | $4.75 | Discretionary |
| Mar 31, 2014 | EVOK | $0 | Other | 164,000 | $N/A | Discretionary |
| Mar 31, 2014 | EVOK | $0 | Other | 164,000 | $N/A | Discretionary |